Screening of acetylcholinesterase inhibitory activity of terpenoid and coumarin derivatives from the genus Ferula

Pharmacologyonline

Volumn 1, Issue , 2010, Pages 566-574

  Karimi, Gholamreza ^a   Iranshahi, Mehrdad ^b   Hosseinalizadeh, Fatemeh ^a   Riahi, Bamdad ^a   Sahebkar, Amirhossein ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acetylcholinesterase inhibition; Coumarin derivatives; Ferula; Terpenoid derivatives

Indexed keywords

7 ISOPENTENYLOXYCOUMARIN; ACETYLCHOLINESTERASE; AURAPTENE; CHOLINESTERASE INHIBITOR; COUMARIN DERIVATIVE; DIVERSIN; DIVERSOLIDE D; FARNESIFEROL A; GALANTAMINE; GALBANIC ACID; HERNIARIN; TERPENOID DERIVATIVE; TSCHIMGINE; UMBELLIFERONE; UMBELLIPRENIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; ERYTHROCYTE; FENNEL; HUMAN; HUMAN CELL; IN VITRO STUDY;

EID: 77953189345     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Roberson MR, Harrell LE. Cholinergic activity and amyloid precursor protein metabolism. Brain Res Rev 1997; 25:50-69.
2. Selkoe DJ. Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 81:741-766, 2001.
3. Terry Jr AV, Buccafusco JJ. The cholinergic hypothesis of age and alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 2003; 306:821-827.
4. Shen Q, Peng Q, Shao J, et al. Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors. Eur J Med Chem 2005; 40:1307-1315.
5. Zhou X, Wang XB, Wang T, Kong LY. Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues. Bioorgan Med Chem 2008; 16:8011-8021.
6. Shvaloff A, Neuman E, Guez D. Lines of therapeutics research in alzheimer's disease. Psychopharmacol Bull 1996; 32:343-352.
7. Wilcock GK. Current approaches to the treatment of alzheimer's disease. Neurodegeneration 1996; 5:505-509.
8. Weinstock M. Possible role of the cholinergic system and disease models. J Neural Transm 1997; [Suppl] 49:93-102.
9. Winkler J, Thal LJ, Gage FH, Fisher LJ. Cholinergic strategies for alzheimer's disease. J Mol Med 1998; 76:555-567.
10. Grutzendler J, Morris JC. Cholinesterase inhibitors for alzheimer's disease. Drugs 2001; 61:41-52.
11. Giacobini E. Pharmacotherapy of alzheimer disease: New drugs and novel strategies. Prog Brain Res 1993; 98:447-454.
12. Enz A, Amstutz R, Boddeke H, Gmelin G, Malanowski J. Brain selective inhibition of acetylcholinesterase: A novel approach to therapy for alzheimer's disease. Prog Brain Res 1993; 98:431-438.
13. Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW. Hepatotoxic effects of tacrine administration in patients with alzheimer's disease. J Am Med Assoc 1994; 271:992-998.
14. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with alzheimer's disease. Neurology 1998; 50:136-145.
15. Evans WC. Trease and Evans' Pharmacognosy, 13th ed. London: Bailliere Tindall, 1989:205-206.
16. Mozaffarian V. The Family of Umbelliferae in Iran-Keys and Distribution. Tehran: Research Institute of Forests and Rangelands Press, 1983:114-116.
17. Mozaffarian V. A Dictionary of Iranian Plant Names. Tehran: Farhang-e Moaser, 1996:228-230.
18. Tamemoto K, Takais Y, Chen B, et al. Sesquiterpenoids from the fruits of Ferula kuhistanica and antibacterial activity of the constituents of F. kuhistanica. Phytochemistry 2001; 58:763-767.
19. Motai T, Daikonya A, Kitanaka S. Sesquiterpene coumarins from Ferula fukanensis and nitric oxide production inhibitory effects. J Nat Prod 2004; 67:432-436.
20. M, Shahverdi AR, Mirjani R, Amin GR, Shafiee A. Umbelliprenin from Ferula persica roots inhibits the red pigment production in Serratia marcescens. Z Naturforsch 2004a; 59 c:506-508.
21. Iranshahi M, Arfa P, Ramezani M, et al. Sesquiterpene coumarins from Ferula szowitsiana and in vitro antileishmanial activity of 7-prenyloxycoumarins against promastigotes. Phytochemistry 2007; 68:554-561.
22. Iranshahi M, Kalategi F, Rezaee R, et al. Cancer chemopreventive activity of terpenoid coumarins from Ferula species. Planta Med 2008a; 74:147-150.
23. Iranshahi M, Amin G, Amini M, Shafiee A. Sulfur containing derivatives from Ferula persica var. latisecta. Phytochemistry 2003; 63:965-966.
24. Iranshahi M, Amin G, Salehi-Sourmaghi MH, Shafiee A, Hadjiakhoondi A. Sulphur-containing compounds in the essential oil of the root of Ferula persica Willd. var. persica. Flav Fragr J 2006; 21:260-261.
25. Zargari A. Medicinal Plants [in Persian]. Vol. 2. Tehran: Tehran University Publications, 1996:592-602.
26. Sayyah M, Mandgary A. Anticonvulsant effect of Ferula gummosa root extract against experimental seizures. Iran Biomed J 2003; 7:139-143.
27. Appendino G, Mercalli E, Fuzzati N, et al. Antimycobacterial coumarins from the Sardinian giant fennel (Ferula communis). J Nat Prod 2004; 67:2108-2110.
28. Fatehi M, Farifteh F, Fatehi-Hassanabad Z. Antispasmodic and hypotensive effects of Ferula asafoetida gum extract. J Ethnopharmacol 2004; 91:321-324.
29. Mandegary A, Sayyah M, Reza Heidari M. Antinociceptive and anti-inflammatory activity of the seed and root extracts of Ferula gummosa Boiss in mice and rats. Daru 2004; 12:58-62.
30. Dehghan G, Shafiee A, Ghahremani MH, Ardestani SK, Abdollahi M. Antioxidant potential of various extracts from Ferula szovitsiana in relation to their phenolic content. Pharm Biol 2007; 45:691-699.
31. Iranshahi M, Fata A, Emami B, Shahri BMJ, Fazly Bazzaz, BS. In vitro antifungal activity of polysulfides-rich essential oil of Ferula latisecta fruits against human pathogenic dermatophytes. Nat Prod Commun 2008b; 3:1543-1546.
32. Asili J, Sahebkar A, Fazly Bazzaz BS, Sharifi S, Iranshahi M. Identification of essential oil components of Ferula badrakema fruits by GC-MS and13C-NMR methods and evaluation of its antimicrobial activity. J Essent Oil-Bear Plants 2009; 12:7-15.
33. Tabernaemontanus DIT. Kräuterbuch, Johann Ludwig König/Johann Brandmüller, Basel, 1687.
34. Miyazawa M, Tougo H, Ishihara M. Inhibition of acetylcholinesterase activity by essential oil from Citrus paradisii. Nat Prod Lett 2001; 15:205-210.
35. Epifano F, Molinaro G, Genovese S, Ngomba RT, Nicoletti F, Curini M. Neuroprotective effect of prenyloxycoumarins from edible vegetables. Neurosci Lett 2008; 443:57-60.
36. Loizzo MR, Tundis R, Menichini F, Menichini F. Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenrative disorders: an update. Curr Med Chem 2008; 15:1209-1228.
37. Iranshahi M, Hosseini ST, Shahverdi AR, Molazade K, Khan SS, Ahmad VU. Diversolides A-G, guaianolides from the roots of Ferula diversivittata Phytochemistry 2008c; 69:2753-2757.
38. Iranshahi M, Amin G, Shafiee A. A new coumarin from Ferula persica. Pharm Biol 2004b; 42:440-442.
39. Askari M, Sahebkar A, Iranshahi M. Synthesis and Purification of 7-Prenyloxycoumarins and Herniarin as Bioactive Natural Coumarins. Iran J Basic Med Sci 2009; 12:63-69.
40. Bagirov VYu, Serkerov SV, Mir-Babaev NF, Pimenov MG. Aromatic esters of Ferula dissecta. Khim Prir Soedin 1984; 1:113-114.
41. Ellman GL, Courtney KD, Andres Jr V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7:88-95.
42. M. Selectivity of cholinesterase inhibition: Clinical implications for the treatment of Alzheimer's disease. 1999; CNS Drugs 12:307-323.
43. Fallarero A, Oinonen P, Gupta S, et al. Inhibition of acetylcholinesterase by coumarins: The case of coumarin 106. Pharmacol Res 2008; 58:215-221.
44. V, Kovarik Z, Radić Z, Reiner E. Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4, 4'-bipyridine and by a coumarin derivative. Chem Biol Interact 1999; 14:119-120:119-127.
45. Brühlmann C, Ooms F, Carrupt PA, et al. Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase. J Med Chem 2001; 44:3195-3198.
46. Kang SY, Lee KY, Sung SH, Park MJ, Kim YC. Coumarins isolated from Angelica gigas inhibit acetylcholinesterase: structure-activity relationships. J Nat Prod 2001; 64:683-685.
47. Urbain A, Marston A, Hostettmann K. Coumarins from peucedanum ostruthium as inhibitors of acetylcholinesterase. Pharm Biol 2005; 43:647-650.
48. Di Giovanni S, Borloz A, Urbain A, et al. In vitro screening assays to identify natural or synthetic acetylcholinesterase inhibitors: thin layer chromatography versus microplatemethods. Eur J Pharm Sci 2008; 33:109-119.
49. Piazzi L, Cavalli A, Colizzi F, et al. Multi-target-directed coumarin derivatives: HAChE and BACE1 inhibitors as potential anti-alzheimer compounds. Bioorg Med Chem Lett 2008; 18:423-426.
50. Ma X, Tan C, Zhu D, Gang DR, Xiao P. Huperzine A from Huperzia species - an ethnopharmacological review. J Ethnopharmacol 2007; 113:15-34.
51. Salminen A, Lehtonen M, Suuronen T, Kaarniranta K, Huuskonen J. Terpenoids: Natural inhibitors of NF-κB signaling with anti-inflammatory and anticancer potential. Cell Mol Life Sci 2008; 65:2979-2999.
52. Jiang YB, Huang SS, Huang LA. Improvement of huperzine A on the deficiency of cognitive and behavior in Alzheimer's disease. Clin Med China 2002; 18:802-803.
53. Zhang Z, Wang X, Chen Q, Shu L, Wang J, Shan G. Clinical efficacy and safety of huperzine alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial. Zhonghua Yi Xue Za Zhi 2002; 82:941-944.
54. Kuang MZ, Xiao WM, Wang SF, Li RX. Clinical evaluation of huperzine A in improving intelligent disorder in patients with Alzheimer's disease. Chin J Clin Rehabil 2004; 8:1216-1217.
55. Wang R, Tang XC. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease. Neurosignals 2005; 14:71-82.
56. Miyazawa M, Yamafuji C. Inhibition of acetylcholinesterase activity by bicyclic monoterpenoids. J Flav Fragr 2006; 21:198-201.
57. Miyazawa M, Yamafuji C. Inhibition of acetylcholinesterase activity by bicyclic monoterpenoids. J Agric Food Chem 2005; 53:1765-1768.
58. Menichini F, Tundis R, Loizzo MR, et al. Acetylcholinesterase and butyrylcholinesterase inhibition of ethanolic extract and monoterpenes from pimpinella anisoides V Brig. (Apiaceae). Fitoterapia 2009; 80:297-300.
59. Perry NSL, Houghton PJ, Theobald A, Jenner P, Perry EK. In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes. J Pharm Pharmacol 2000; 52:895-902.
60. Savelev S, Okello E, Perry NSL, Wilkins RM, Perry EK. Synergistic and antagonistic interactions of anticholinesterase terpenoids in salvia lavandulaefolia essential oil. Pharm Biochem Behav 2003; 75:661-668.
61. Kumar P, Singh VK, Singh DK. Kinetics of enzyme inhibition by active molluscicidal agents ferulic acid, umbelliferone, eugenol and limonene in the nervous tissue of snail lymnaea acuminata. Phytother Res 2009; 23:172-177.
62. Borisov VN, Ban'kovskii AI, Sheichenko VI, Kabanov VS. Auraptene from Ferula microloba. Chem Nat Comp 1976; 10:672.
63. Barthomeuf C, Lim S, Iranshahi M, Chollet P. Umbelliprenin from Ferula szowitsiana inhibits the growth of human M4Beu metastatic pigmented malignant melanoma cells through cell-cycle arrest in G1 and induction of caspase-dependent apoptosis. Phytomedicine 2008; 15:103-111.
64. Ikeda K, Arao Y, Otsuka H, Nomoto S, et al. Terpenoids found in the umbelliferae family act as agonists/antagonists for ERα and ERβ: Differential transcription activity between ferutinine-liganded ERα and ERβ. Biochem Biophys Res Commun 2002; 291:354-360.